市場調査レポート

商品コード

1317748

白血病治療薬市場：タイプ別、治療タイプ別、分子タイプ別、投与形態別、性別-2023～2030年の世界予測

Leukemia Therapeutics Market by Type, Treatment Type, Molecule Type, Mode of Administration, Gender - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日: 2023年06月12日 | 発行: 360iResearch

| ページ情報: 英文 181 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF, Excel & Online Access - 1 Year (Single User License)

USD 4,749 754,948円

レポートPDF及びExcelを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Up to 5 User License)

USD 5,749 913,918円

レポートPDF及びExcelを5名まで共有ご利用頂けるライセンスです。ご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Site License)

USD 6,749 1,072,888円

レポートPDF及びExcelを同一事業所（所在地）内のすべての方でご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Enterprise User License)

USD 8,749 1,390,828円

レポートPDF及びExcelを同一企業の全世界の方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=158.97円

ご注意事項 :

本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

白血病治療薬の世界市場は、2023年に156億4,000万米ドル、CAGR 7.00%で大きく成長し、2030年には251億7,000万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の白血病治療薬市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.白血病治療薬の世界市場規模および予測は？

2.予測期間中、世界の白血病治療薬市場を形成するCOVID-19の阻害要因と影響は？

3.白血病治療薬の世界市場において予測期間中に投資すべき製品/セグメント/用途/分野は？

4.白血病治療薬の世界市場における競争戦略は？

5.白血病治療薬の世界市場における技術動向と規制の枠組みは？

6.白血病治療薬の世界市場における主要ベンダーの市場シェアは？

7.白血病治療薬の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

市場力学
- 促進要因
  - 白血病の有病率の上昇
  - がん治療の必要性の高まり
  - ヘルスケア分野への投資の増加
- 抑制要因
  - 高額な治療費と新しい治療法の開発
- 機会
  - 白血病患者のための革新的な診断薬と治療薬の開発
  - ヘルスケア分野への投資拡大と政府の有利な取り組み
- 課題
  - 厳しい規制シナリオ
市場動向
COVID-19の累積的な影響
ロシア・ウクライナ紛争の累積的影響
高インフレの累積的影響
ポーターのファイブフォース分析
バリューチェーンとクリティカルパス分析
規制の枠組み
顧客のカスタマイズ

第6章白血病治療薬市場：タイプ別

イントロダクション
急性リンパ性白血病
急性骨髄性白血病
慢性リンパ性白血病
慢性骨髄性白血病

第7章白血病治療薬市場：治療タイプ別

イントロダクション
化学療法
標的薬物と免疫療法

第8章白血病治療薬市場：分子タイプ別

イントロダクション
生物製剤
低分子

第9章白血病治療薬市場：投与形態別

イントロダクション
注射
経口

第10章白血病治療薬市場：性別

イントロダクション
女性
男性

第11章南北アメリカの白血病治療薬市場

イントロダクション
アルゼンチン
ブラジル
カナダ
メキシコ
米国

第12章アジア太平洋地域の白血病治療薬市場

イントロダクション
オーストラリア
中国
インド
インドネシア
日本
マレーシア
フィリピン
シンガポール
韓国
台湾
タイ
ベトナム

第13章欧州・中東・アフリカの白血病治療薬市場

イントロダクション
デンマーク
エジプト
フィンランド
フランス
ドイツ
イスラエル
イタリア
オランダ
ナイジェリア
ノルウェー
ポーランド
カタール
ロシア
サウジアラビア
南アフリカ
スペイン
スウェーデン
スイス
トルコ
アラブ首長国連邦
英国

第14章競合情勢

FPNVポジショニングマトリクス
市場シェア分析：主要企業別
競合シナリオ分析：主要企業別

第15章掲載企業一覧

第16章付録

ディスカッションガイド
ライセンスと価格について

図表

LIST OF FIGURES

FIGURE 1. LEUKEMIA THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 2. LEUKEMIA THERAPEUTICS MARKET SIZE, 2022 VS 2030
FIGURE 3. LEUKEMIA THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
FIGURE 5. LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2022 VS 2030 (%)
FIGURE 6. LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2022 VS 2030 (%)
FIGURE 7. LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2022 VS 2030 (%)
FIGURE 8. LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2022 VS 2030 (%)
FIGURE 9. LEUKEMIA THERAPEUTICS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 10. LEUKEMIA THERAPEUTICS MARKET DYNAMICS
FIGURE 11. LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 12. LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS LEUKEMIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES LEUKEMIA THERAPEUTICS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC LEUKEMIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA LEUKEMIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 20. LEUKEMIA THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 21. LEUKEMIA THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

TABLE 1. LEUKEMIA THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. LEUKEMIA THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 5. LEUKEMIA THERAPEUTICS MARKET SIZE, BY ACUTE LYMPHOCYTIC LEUKEMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 6. LEUKEMIA THERAPEUTICS MARKET SIZE, BY ACUTE MYELOID LEUKEMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. LEUKEMIA THERAPEUTICS MARKET SIZE, BY CHRONIC LYMPHOCYTIC LEUKEMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. LEUKEMIA THERAPEUTICS MARKET SIZE, BY CHRONIC MYELOID LEUKEMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 10. LEUKEMIA THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. LEUKEMIA THERAPEUTICS MARKET SIZE, BY TARGETED DRUGS & IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 13. LEUKEMIA THERAPEUTICS MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. LEUKEMIA THERAPEUTICS MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 16. LEUKEMIA THERAPEUTICS MARKET SIZE, BY INJECTABLE MODE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. LEUKEMIA THERAPEUTICS MARKET SIZE, BY ORAL MODE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 19. LEUKEMIA THERAPEUTICS MARKET SIZE, BY FEMALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. LEUKEMIA THERAPEUTICS MARKET SIZE, BY MALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS LEUKEMIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 37. CANADA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 38. CANADA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 39. CANADA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 40. CANADA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 41. CANADA LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 42. MEXICO LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 43. MEXICO LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 44. MEXICO LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 45. MEXICO LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 46. MEXICO LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES LEUKEMIA THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC LEUKEMIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 59. AUSTRALIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. AUSTRALIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 61. AUSTRALIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 62. AUSTRALIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 63. AUSTRALIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 64. CHINA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. CHINA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 66. CHINA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 67. CHINA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 68. CHINA LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 69. INDIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 70. INDIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 71. INDIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 72. INDIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 73. INDIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 74. INDONESIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. INDONESIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 76. INDONESIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 77. INDONESIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 78. INDONESIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 79. JAPAN LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. JAPAN LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 81. JAPAN LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 82. JAPAN LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 83. JAPAN LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 84. MALAYSIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. MALAYSIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 86. MALAYSIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 87. MALAYSIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 88. MALAYSIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 89. PHILIPPINES LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 90. PHILIPPINES LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 91. PHILIPPINES LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 92. PHILIPPINES LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 93. PHILIPPINES LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 94. SINGAPORE LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. SINGAPORE LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 96. SINGAPORE LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 97. SINGAPORE LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 98. SINGAPORE LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 99. SOUTH KOREA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. SOUTH KOREA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 101. SOUTH KOREA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 102. SOUTH KOREA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 103. SOUTH KOREA LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 104. TAIWAN LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 105. TAIWAN LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 106. TAIWAN LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 107. TAIWAN LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 108. TAIWAN LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 109. THAILAND LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 110. THAILAND LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 111. THAILAND LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 112. THAILAND LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 113. THAILAND LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 114. VIETNAM LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 115. VIETNAM LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 116. VIETNAM LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 117. VIETNAM LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 118. VIETNAM LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA LEUKEMIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 125. DENMARK LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 126. DENMARK LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 127. DENMARK LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 128. DENMARK LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 129. DENMARK LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 130. EGYPT LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 131. EGYPT LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 132. EGYPT LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 133. EGYPT LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 134. EGYPT LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 135. FINLAND LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. FINLAND LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 137. FINLAND LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 138. FINLAND LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 139. FINLAND LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 140. FRANCE LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 141. FRANCE LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 142. FRANCE LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 143. FRANCE LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 144. FRANCE LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 145. GERMANY LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 146. GERMANY LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 147. GERMANY LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 148. GERMANY LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 149. GERMANY LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 150. ISRAEL LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 151. ISRAEL LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 152. ISRAEL LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 153. ISRAEL LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 154. ISRAEL LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 155. ITALY LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 156. ITALY LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 157. ITALY LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 158. ITALY LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 159. ITALY LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 160. NETHERLANDS LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 161. NETHERLANDS LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 162. NETHERLANDS LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 163. NETHERLANDS LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 165. NIGERIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 166. NIGERIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 167. NIGERIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 168. NIGERIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 169. NIGERIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 170. NORWAY LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 171. NORWAY LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 172. NORWAY LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 173. NORWAY LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 174. NORWAY LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 175. POLAND LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 176. POLAND LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 177. POLAND LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 178. POLAND LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 179. POLAND LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 180. QATAR LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 181. QATAR LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 182. QATAR LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 183. QATAR LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 184. QATAR LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 185. RUSSIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 186. RUSSIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 187. RUSSIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 188. RUSSIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 190. SAUDI ARABIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 191. SAUDI ARABIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 192. SAUDI ARABIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 195. SOUTH AFRICA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 196. SOUTH AFRICA LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 197. SOUTH AFRICA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 200. SPAIN LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 201. SPAIN LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 202. SPAIN LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 203. SPAIN LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 204. SPAIN LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 205. SWEDEN LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 206. SWEDEN LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 207. SWEDEN LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 210. SWITZERLAND LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 211. SWITZERLAND LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 212. SWITZERLAND LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 213. SWITZERLAND LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 214. SWITZERLAND LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 215. TURKEY LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 216. TURKEY LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 217. TURKEY LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 218. TURKEY LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 219. TURKEY LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM LEUKEMIA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 226. UNITED KINGDOM LEUKEMIA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM LEUKEMIA THERAPEUTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 228. UNITED KINGDOM LEUKEMIA THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM LEUKEMIA THERAPEUTICS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 230. LEUKEMIA THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 231. LEUKEMIA THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 232. LEUKEMIA THERAPEUTICS MARKET LICENSE & PRICING

Product Code: MRR-4342CA3265CB

The Global Leukemia Therapeutics Market is forecasted to grow significantly, with a projected USD 15.64 billion in 2023 at a CAGR of 7.00% and expected to reach a staggering USD 25.17 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Leukemia Therapeutics Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Leukemia Therapeutics Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, and Chronic Myeloid Leukemia. The Chronic Lymphocytic Leukemia is projected to witness significant market share during forecast period.

Based on Treatment Type, market is studied across Chemotherapy and Targeted Drugs & Immunotherapy. The Targeted Drugs & Immunotherapy is projected to witness significant market share during forecast period.

Based on Molecule Type, market is studied across Biologics and Small Molecules. The Biologics is projected to witness significant market share during forecast period.

Based on Mode of Administration, market is studied across Injectable Mode and Oral Mode. The Oral Mode is projected to witness significant market share during forecast period.

Based on Gender, market is studied across Female and Male. The Male is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Leukemia Therapeutics Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Leukemia Therapeutics Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Leukemia Therapeutics Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Leukemia Therapeutics Market?

4. What is the competitive strategic window for opportunities in the Global Leukemia Therapeutics Market?

5. What are the technology trends and regulatory frameworks in the Global Leukemia Therapeutics Market?

6. What is the market share of the leading vendors in the Global Leukemia Therapeutics Market?

7. What modes and strategic moves are considered suitable for entering the Global Leukemia Therapeutics Market?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Leukemia Therapeutics Market, by Type, 2022 vs 2030
4.3. Leukemia Therapeutics Market, by Treatment Type, 2022 vs 2030
4.4. Leukemia Therapeutics Market, by Molecule Type, 2022 vs 2030
4.5. Leukemia Therapeutics Market, by Mode of Administration, 2022 vs 2030
4.6. Leukemia Therapeutics Market, by Gender, 2022 vs 2030
4.7. Leukemia Therapeutics Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Rising prevalence of leukemia cases
  - 5.1.1.2. Growing need for cancer therapy
  - 5.1.1.3. Increasing investment in healthcare sector
- 5.1.2. Restraints
  - 5.1.2.1. High cost of treatment and development of new therapeutics
- 5.1.3. Opportunities
  - 5.1.3.1. Development of innovative diagnostic and therapeutics for leukemia patients
  - 5.1.3.2. Expanding investments in the healthcare sector and favorable government initiatives
- 5.1.4. Challenges
  - 5.1.4.1. Stringent regulatory scenario
5.2. Market Trends
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization

6. Leukemia Therapeutics Market, by Type

6.1. Introduction
6.2. Acute Lymphocytic Leukemia
6.3. Acute Myeloid Leukemia
6.4. Chronic Lymphocytic Leukemia
6.5. Chronic Myeloid Leukemia

7. Leukemia Therapeutics Market, by Treatment Type

7.1. Introduction
7.2. Chemotherapy
7.3. Targeted Drugs & Immunotherapy

8. Leukemia Therapeutics Market, by Molecule Type

8.1. Introduction
8.2. Biologics
8.3. Small Molecules

9. Leukemia Therapeutics Market, by Mode of Administration

9.1. Introduction
9.2. Injectable Mode
9.3. Oral Mode

10. Leukemia Therapeutics Market, by Gender

10.1. Introduction
10.2. Female
10.3. Male

11. Americas Leukemia Therapeutics Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Leukemia Therapeutics Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Leukemia Therapeutics Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

白血病治療薬市場：タイプ別、治療タイプ別、分子タイプ別、投与形態別、性別-2023～2030年の世界予測

Leukemia Therapeutics Market by Type, Treatment Type, Molecule Type, Mode of Administration, Gender - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

FPNVポジショニング・マトリックス

市場シェア分析

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

第6章 白血病治療薬市場：タイプ別

第7章 白血病治療薬市場：治療タイプ別

第8章 白血病治療薬市場：分子タイプ別

第9章 白血病治療薬市場：投与形態別

第10章 白血病治療薬市場：性別

第11章 南北アメリカの白血病治療薬市場

第12章 アジア太平洋地域の白血病治療薬市場

第13章 欧州・中東・アフリカの白血病治療薬市場

第14章 競合情勢

第15章 掲載企業一覧

第16章 付録